Quarterly report pursuant to Section 13 or 15(d)

Royalty Purchase Agreements (Tables)

v3.19.3
Royalty Purchase Agreements (Tables)
9 Months Ended
Sep. 30, 2019
Royalty Purchase Agreement [Abstract]  
Summary of Acquisition of Royalty Rights

The following table summarizes the acquisition of royalty rights as of September 30, 2019 (in thousands):

 

Balance at December 31, 2018

 

$

15,000

 

Acquisition of royalty rights:

 

 

 

 

Bioasis

 

 

375

 

Aronora

 

 

9,000

 

Palobiofarma

 

 

10,000

 

Balance at September 30, 2019

 

$

34,375